The Administrative Core will also be responsible for the day-to-day fiscal management of the Program, in collaboration with the Director of Finance at Boston Medical Center. Supply and equipment purchases, personnel appointments and travel expenses will be processed through this office. Each responsible investigator will receive a monthly statement of the financial status of his project, including monthly and cumulative expenditures and projected spending. All projects will be evaluated in detail annually by the External Advisory Committee and by the Internal Advisory Committee on an ad hoc basis (see Organization and Administration). Important changes in content or direction will require prior approval from the Program Director and the NIH. Monthly seminars will be held for the scientists in this program. New research developments within the program and summaries of papers presented at scientific conferences will be discussed. In addition, scientists from other institutions will be invited to present their work. Several other conferences under the direction of participants in this program will also be available to our group. These include the conferences of the Vascular Biology Unit (Dr. Cohen), the Section of Endocrinology, Diabetes and Metabolism (Dr. Ruderman) the PPG Endothelial Cell Redox State in Health and Disease (Dr. Walsh, and the Cardiovascular Institute (all investigators). As noted in the General Introduction, guest speakers invited by us to these conferences in the past four years have included, Drs. Michael Brownlee, David Carling, Lawrence Chan, Michael Gimbrone, Graham Hardie, George King and Roger Linger.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Boston Medical Center
United States
Zip Code
Mei, Yu; Thompson, Melissa D; Cohen, Richard A et al. (2015) Autophagy and oxidative stress in cardiovascular diseases. Biochim Biophys Acta 1852:243-51
Ngo, Doan T M; Farb, Melissa G; Kikuchi, Ryosuke et al. (2014) Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity. Circulation 130:1072-80
Shao, Di; Fry, Jessica L; Han, Jingyan et al. (2014) A redox-resistant sirtuin-1 mutant protects against hepatic metabolic and oxidant stress. J Biol Chem 289:7293-306
Krasner, Nadia M; Ido, Yasuo; Ruderman, Neil B et al. (2014) Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism. PLoS One 9:e97554
Shimizu, Ippei; Aprahamian, Tamar; Kikuchi, Ryosuke et al. (2014) Vascular rarefaction mediates whitening of brown fat in obesity. J Clin Invest 124:2099-112
Yoshida, Sumiko; Fuster, José Javier; Walsh, Kenneth (2014) Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. Atherosclerosis 235:339-46
Parker-Duffen, Jennifer L; Walsh, Kenneth (2014) Cardiometabolic effects of adiponectin. Best Pract Res Clin Endocrinol Metab 28:81-91
Farb, Melissa G; Tiwari, Stephanie; Karki, Shakun et al. (2014) Cyclooxygenase inhibition improves endothelial vasomotor dysfunction of visceral adipose arterioles in human obesity. Obesity (Silver Spring) 22:349-55
Parker-Duffen, Jennifer L; Nakamura, Kazuto; Silver, Marcy et al. (2014) Divergent roles for adiponectin receptor 1 (AdipoR1) and AdipoR2 in mediating revascularization and metabolic dysfunction in vivo. J Biol Chem 289:16200-13
Akasaki, Yuichi; Ouchi, Noriyuki; Izumiya, Yasuhiro et al. (2014) Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism. Aging Cell 13:80-91

Showing the most recent 10 out of 79 publications